1. Home
  2. RELI vs SPRC Comparison

RELI vs SPRC Comparison

Compare RELI & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RELI
  • SPRC
  • Stock Information
  • Founded
  • RELI 2013
  • SPRC 2004
  • Country
  • RELI United States
  • SPRC Israel
  • Employees
  • RELI N/A
  • SPRC N/A
  • Industry
  • RELI Specialty Insurers
  • SPRC Biotechnology: Pharmaceutical Preparations
  • Sector
  • RELI Finance
  • SPRC Health Care
  • Exchange
  • RELI Nasdaq
  • SPRC Nasdaq
  • Market Cap
  • RELI 3.5M
  • SPRC 3.4M
  • IPO Year
  • RELI N/A
  • SPRC N/A
  • Fundamental
  • Price
  • RELI $2.12
  • SPRC $0.30
  • Analyst Decision
  • RELI
  • SPRC
  • Analyst Count
  • RELI 0
  • SPRC 0
  • Target Price
  • RELI N/A
  • SPRC N/A
  • AVG Volume (30 Days)
  • RELI 3.6M
  • SPRC 196.1K
  • Earning Date
  • RELI 07-24-2025
  • SPRC 02-15-2025
  • Dividend Yield
  • RELI N/A
  • SPRC N/A
  • EPS Growth
  • RELI N/A
  • SPRC N/A
  • EPS
  • RELI N/A
  • SPRC N/A
  • Revenue
  • RELI $14,208,143.00
  • SPRC $1,306,000.00
  • Revenue This Year
  • RELI N/A
  • SPRC N/A
  • Revenue Next Year
  • RELI N/A
  • SPRC N/A
  • P/E Ratio
  • RELI N/A
  • SPRC N/A
  • Revenue Growth
  • RELI 2.40
  • SPRC N/A
  • 52 Week Low
  • RELI $0.97
  • SPRC $0.20
  • 52 Week High
  • RELI $5.11
  • SPRC $1.79
  • Technical
  • Relative Strength Index (RSI)
  • RELI 61.88
  • SPRC 49.11
  • Support Level
  • RELI $1.88
  • SPRC $0.29
  • Resistance Level
  • RELI $2.60
  • SPRC $0.34
  • Average True Range (ATR)
  • RELI 0.36
  • SPRC 0.02
  • MACD
  • RELI 0.08
  • SPRC -0.00
  • Stochastic Oscillator
  • RELI 52.85
  • SPRC 33.33

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: